NICOLE JASINSKI: Open Payments
NPI 1447081690 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 38 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $3,474 · 2025 $1,141
Food & beverage: $1,088Travel & lodging: $53
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $233 |
| ABBVIE INC. | 6 | $172 |
| PFIZER INC. | 7 | $166 |
| SK Life Science, Inc. | 2 | $165 |
| TG Therapeutics, Inc. | 2 | $56 |
| GENZYME CORPORATION | 2 | $56 |
| Eisai Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $43 |
| Novo Nordisk Inc | 1 | $33 |
| UCB, Inc. | 1 | $28 |
Products named: INFINITY, OCTAGAM IMMUNE GLOBULIN (HUMAN), QULIPTA, BRIUMVI, UBRELVY, Leqembi, KISUNLA, Rystiggo.
Industry payments across NY — which companies pay providers there.
